J F Colombel

Impact of the Mobile HealthPROMISE Platform on the Quality of Care and Quality of Life in Patients With Inflammatory Bowel Disease: Study Protocol of a Pragmatic Randomized Controlled Trial

Ashish Atreja, Sameer Khan, J Rogers et al. · JMIR Research Protocols · 2015 · 79 citations · Full text

Pharmacy, Health Informatics, Internal Medicine +17

IBD Around the world: Comparing the epidemiology, diagnosis, and treatment

Daniel C. Baumgart, Çharles N. Bernstein, Zaigham Abbas et al. · Inflammatory Bowel Diseases · 2010 · 77 citations

Medicine, Internal Medicine, Epidemiology +8

Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine

Bruno Bonaz, J. Boitard, Philippe Marteau et al. · Alimentary Pharmacology & Therapeutics · 2003 · 71 citations

Medicine, Pharmacology, Pharmacotherapy +11

P178 EARLY CROHN'S DISEASE SHOWS HIGH LEVELS OF REMISSION TO THERAPY WITH ADALIMUMAB: SUB-ANALYSIS OF CHARM

Stefanie Schreiber, Walter Reinisch, J F Colombel et al. · Journal of Crohn s and Colitis Supplements · 2007 · 67 citations · Full text

Medicine, Immunology, Pathology +17

Escalation to weekly dosing recaptures response in adalimumab‐treated patients with moderately to severely active ulcerative colitis

Douglas C. Wolf, Geert D’Haens, William J. Sandborn et al. · Alimentary Pharmacology & Therapeutics · 2014 · 61 citations

Pharmacy, Clinical Sciences, Immunology +17